Integrative Multi-Omics in Biomedical Research
Genomics technologies revolutionised biomedicine research, but the genome alone is not sufficient to capture biological complexity. Postgenomic methods, typically based on mass spectrometry, comprise the analysis of metabolites, lipids, and proteins and are an essential complement to genomics and tr...
Saved in:
Other Authors: | , |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_77086 | ||
005 | 20220111 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20220111s2021 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-2583-9 | ||
020 | |a 9783036525822 | ||
020 | |a 9783036525839 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-2583-9 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Gerner, Christopher |4 edt | |
700 | 1 | |a Hill, Michelle |4 edt | |
700 | 1 | |a Gerner, Christopher |4 oth | |
700 | 1 | |a Hill, Michelle |4 oth | |
245 | 1 | 0 | |a Integrative Multi-Omics in Biomedical Research |
260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
300 | |a 1 electronic resource (178 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Genomics technologies revolutionised biomedicine research, but the genome alone is not sufficient to capture biological complexity. Postgenomic methods, typically based on mass spectrometry, comprise the analysis of metabolites, lipids, and proteins and are an essential complement to genomics and transcriptomics. Multidimensional omics is becoming established to provide accurate and comprehensive state descriptions. This book covers the latest methodological developments for, and applications of integrative multi-omics in biomedical research. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a target identification | ||
653 | |a target validation | ||
653 | |a label-free method for drugs | ||
653 | |a anti-angiogenesis | ||
653 | |a mechanism of action | ||
653 | |a receptor tyrosine kinases | ||
653 | |a curcumin | ||
653 | |a natural products | ||
653 | |a lipid | ||
653 | |a lipidomics | ||
653 | |a cardiac metaplasia | ||
653 | |a Barrett's esophagus | ||
653 | |a esophageal adenocarcinoma | ||
653 | |a microbiota | ||
653 | |a DNA sensing | ||
653 | |a IFI16 | ||
653 | |a cGAS | ||
653 | |a innate immunity | ||
653 | |a protein interactions | ||
653 | |a virus-host interactions | ||
653 | |a post-translational modifications | ||
653 | |a mass spectrometry | ||
653 | |a proteomics | ||
653 | |a transcriptomics | ||
653 | |a multi-omics | ||
653 | |a multi-omics analysis | ||
653 | |a study design | ||
653 | |a bioinformatics | ||
653 | |a machine learning | ||
653 | |a analysis flow | ||
653 | |a metabolomics | ||
653 | |a planned myocardial infarction (PMI) | ||
653 | |a myocardial infarction (MI) | ||
653 | |a exercise | ||
653 | |a heart | ||
653 | |a cheminformatics | ||
653 | |a batch variations | ||
653 | |a eicosanoids | ||
653 | |a fetal calf serum | ||
653 | |a peroxisomes | ||
653 | |a host-pathogen interactions | ||
653 | |a secretome | ||
653 | |a macrophages | ||
653 | |a acute myeloid leukemia | ||
653 | |a HL-60 cell line | ||
653 | |a ATRA | ||
653 | |a induced differentiation | ||
653 | |a transcriptome | ||
653 | |a proteome | ||
653 | |a transcription factors | ||
653 | |a key molecules | ||
653 | |a regulatory pathway modelling | ||
653 | |a SRM | ||
653 | |a endometriosis | ||
653 | |a inflammation | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4705 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/77086 |7 0 |z DOAB: description of the publication |